American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal
Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults
with obesity
Jirapinyo, Pichamol ✉; Hadefi, Alia*; Thompson, Christopher C; Patai, Árpád V [Patai, Árpád V (Belgyógyászat), szerző] Sebészeti, Transzplantációs
és Gasztroenterológ... (SE / AOK / K); Pannala, Rahul; Goelder, Stefan K; Kushnir, Vladimir; Barthet, Marc; Apovian, Caroline M; Boskoski, Ivo; Chapman, Christopher G; Davidson, Paul; Donatelli, Gianfranco; Kumbhari, Vivek; Hayee, Bu; Esker, Janelle; Hucl, Tomas; Pryor, Aurora D; Maselli, Roberta; Schulman, Allison R; Pattou, Francois; Zelber-Sagi, Shira; Bain, Paul A; Durieux, Valérie; Triantafyllou, Konstantinos; Thosani, Nirav; Huberty, Vincent**; Sullivan, Shelby
Angol nyelvű Utánközlés (Folyóiratcikk) Tudományos
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations
regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the
management of obesity. The document was developed using the Grading of Recommendations,
Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy
and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval,
or that had been approved within five years of document development. The guideline
suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥
30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity.
Furthermore, it suggests the utilization of intragastric balloons and devices for
endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for
this patient population.
